A novel human skeletal muscle in vitro model using opti-ox™ mediated cellular reprogramming of induced pluripotent stem cells

POSTER A novel human skeletal muscle in vitro model using opti-ox™ mediated cellular reprogramming of induced pluripotent stem cells Bernard, et al. 2020. bit.bio Summary We have developed an optimised inducible system (opti-ox™) that enables tightly controlled...

High Content Analysis of 2D and 3D cellular models for target and phenotypic drug discovery

POSTER High Content Analysis of 2D and 3D cellular models for target and phenotypic drug discovery Lachize, et al. 2020. Courtesy of Charles River Summary Charles River Laboratories (CRL) has developed many disease-relevant cellular models to screen small molecules...

Introducing human iPSC derived muscle cells for research and drug discovery

WEBINAR Introducing human iPSC derived muscle cells for research and drug discovery Dr Will Bernard, Senior Scientist (bit.bio), Dr Luke Flatt, Senior Scientist (Charles River). 2020 Summary Introducing the first human iPSC-derived skeletal myocyte   Learn how...

Advances in cellular reprogramming: from stem cells to printed tissues

WEBINAR Advances in cellular reprogramming: from stem cells to printed tissues Prof Hagan Bayley, University of Oxford & Dr Mark Kotter, Founder & CEO bit.bio. 2020 Summary A scalable technology platform capable of producing consistent batches of every human...